Related Experiment Video

Updated: Aug 9, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Costs of occupational circulatory disease

J P Leigh, P Schnall

    Occupational Medicine (Philadelphia, Pa.)
    |March 4, 2000
    PubMed

    Insights

    This study reveals that individuals and society bear the primary economic burden of work-related cardiovascular diseases (CVD), not employers. It explores economic strategies to promote public health interventions for CVD prevention.

    Area of Science:

    • Public Health
    • Occupational Health
    • Health Economics

    Background:

    • Work-related cardiovascular diseases (CVD) represent a significant public health concern with substantial economic implications.
    • Existing research often overlooks the full spectrum of costs associated with occupational CVD.
    • Understanding the economic burden is crucial for developing effective prevention strategies.

    Purpose of the Study:

    • To analyze the overt and hidden economic costs of work-related cardiovascular diseases.
    • To identify who bears the financial burden of these diseases.
    • To explore economic interventions for motivating public health approaches to CVD prevention.

    Main Methods:

    • Economic cost analysis of work-related cardiovascular diseases.
    • Review of literature on the financial impact of occupational CVD.
    • Exploration of economic intervention models for public health.

    Main Results:

    • The majority of economic costs associated with work-related CVD are borne by affected individuals and society.
    • Employers are not the primary financial stakeholders in work-related CVD costs.
    • Economic interventions can be designed to incentivize public health initiatives.

    Conclusions:

    • Addressing the economic burden of work-related CVD requires a societal and individual-focused approach.
    • Public health interventions are vital for mitigating the financial impact of occupational CVD.
    • Economic incentives can play a key role in promoting CVD prevention in the workplace and beyond.

    More Related Videos

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

    Published on: August 9, 2024

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians04:03

    Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

    Published on: September 27, 2024

    Related Concept Videos

    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    Chronic Obstructive Pulmonary Disease-I: Introduction01:20

    Chronic Obstructive Pulmonary Disease-I: Introduction

    Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

    Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

    Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
    Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
    Primary Symptoms of COPD:
    Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

    Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

    Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
    Medical History
    Assessment of the Cardiovascular System II: Inspection01:29

    Assessment of the Cardiovascular System II: Inspection

    Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
    Head and Neck
    Chronic Obstructive Pulmonary Disease I: Introduction01:23

    Chronic Obstructive Pulmonary Disease I: Introduction

    Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...